Sabra Healthcare REIT, Inc. (SBRA) Rating Increased to Hold at BidaskClub
Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) was upgraded by equities researchers at BidaskClub from a “sell” rating to a “hold” rating in a note issued to investors on Tuesday.
Several other research analysts also recently weighed in on the company. Canaccord Genuity reaffirmed a “hold” rating and set a $26.00 target price on shares of Sabra Healthcare REIT in a research note on Tuesday, May 9th. Zacks Investment Research raised Sabra Healthcare REIT from a “hold” rating to a “buy” rating and set a $32.00 target price for the company in a research note on Wednesday, April 12th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $30.00 target price on shares of Sabra Healthcare REIT in a research note on Monday, May 8th. Jefferies Group LLC reaffirmed a “hold” rating and set a $28.00 target price on shares of Sabra Healthcare REIT in a research note on Friday, May 12th. Finally, Mizuho reaffirmed a “neutral” rating and set a $28.00 target price (up from $22.00) on shares of Sabra Healthcare REIT in a research note on Monday, February 27th. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and two have given a buy rating to the company. Sabra Healthcare REIT presently has an average rating of “Hold” and an average price target of $27.71.
Sabra Healthcare REIT (NASDAQ SBRA) traded up 0.96% during midday trading on Tuesday, reaching $24.18. 2,368,466 shares of the company’s stock were exchanged. The firm has a market capitalization of $1.58 billion, a price-to-earnings ratio of 16.71 and a beta of 1.00. The firm’s 50 day moving average is $24.15 and its 200 day moving average is $25.59. Sabra Healthcare REIT has a 52 week low of $19.30 and a 52 week high of $29.10.
Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings data on Monday, May 8th. The real estate investment trust reported $0.25 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.58 by $0.33. Sabra Healthcare REIT had a return on equity of 10.35% and a net margin of 40.22%. The company had revenue of $62.65 million during the quarter, compared to analysts’ expectations of $63.47 million. During the same quarter in the prior year, the company posted $0.54 EPS. The company’s revenue for the quarter was up .1% on a year-over-year basis. On average, equities analysts anticipate that Sabra Healthcare REIT will post $1.20 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 31st. Stockholders of record on Thursday, May 18th were issued a dividend of $0.43 per share. The ex-dividend date of this dividend was Tuesday, May 16th. This is a boost from Sabra Healthcare REIT’s previous quarterly dividend of $0.42. This represents a $1.72 dividend on an annualized basis and a dividend yield of 7.11%. Sabra Healthcare REIT’s dividend payout ratio is currently 119.45%.
Several institutional investors have recently added to or reduced their stakes in SBRA. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Sabra Healthcare REIT by 14.2% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,799 shares of the real estate investment trust’s stock worth $106,000 after buying an additional 471 shares in the last quarter. Bank of Montreal Can boosted its position in shares of Sabra Healthcare REIT by 44.1% in the first quarter. Bank of Montreal Can now owns 3,893 shares of the real estate investment trust’s stock worth $109,000 after buying an additional 1,191 shares during the period. Russell Investments Group Ltd. purchased a new position in shares of Sabra Healthcare REIT during the fourth quarter worth approximately $120,000. Ameritas Investment Partners Inc. purchased a new position in shares of Sabra Healthcare REIT during the first quarter worth approximately $156,000. Finally, Stratos Wealth Partners LTD. purchased a new position in shares of Sabra Healthcare REIT during the first quarter worth approximately $207,000. Institutional investors and hedge funds own 99.47% of the company’s stock.
Sabra Healthcare REIT Company Profile
Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.
Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with MarketBeat.com's FREE daily email newsletter.